Agendia And Agilent Announce Plans To Jointly Develop New Di

AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop new in-vitro diagnostic tests.

Related Keywords

Amsterdam , Noord Holland , Netherlands , California , United States , Yvonne Linney , Agendia Mammaprint , Kelly Connor , Stuart Matlow , Agilent Agendia , Drug Administration , Agilent Technologies , Agilent Technologies Inc , Bernhard Sixt , United States Food , Unknown Primary , For Agendia , For Agilent , Bernhard Sixt Stuart Matlow , Vice President , Ogilvy Public Relations Worldwide , Cancer Research ,